WebAt Hikma, we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. WebApr 18, 2024 · As a condition of Hikma Pharmaceuticals PLC’s $375 million acquisition of generic drug services company Custopharm, Inc., the Federal Trade Commission required Custopharm’s parent company, private equity fund Water Street Healthcare Partners, LLC to retain and transfer Custopharm’s assets related to the corticosteroid …
Hikma Launches New 503B Sterile Compounding Business - PR …
WebMar 21, 2024 · The company's largest shareholder is Darhold Ltd., with ownership of 26%. Meanwhile, the second and third largest shareholders, hold 7.2% and 5.0%, of the shares outstanding, respectively. WebFigures. Hikma Pharmaceuticals Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company. Hikma Pharmaceuticals Plc (Hikma ... family\\u0027s i
Jefferson County, MO Official Website
WebCompany profile page for Hikma Pharmaceuticals PLC including stock price, company news, press releases, executives, board members, and contact information WebHikma Pharmaceuticals Plc (Hikma Pharmaceuticals) develops, manufactures and markets a broad range of branded, non-branded generic, as well as in-licensed products. Focus on R&D, increase in working capital and strong market position are its strengths, whereas legal proceedings could be an area of concern. Approvals and launch new products ... WebAug 3, 2016 · Broad portfolio of over 760 high-quality products across three businesses. Agile supply chain, flexible manufacturing and leading technical capabilities. Leading supplier of both generic injectable and non … family\\u0027s i2